Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2021. Forecast tables and graphs.

Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2021

The forecast has been updated: June 11, 2021 9:28


Biohaven Pharmaceutical Holding stock price online today

Analyst Target Price

101.45

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Biohaven Pharmaceutical Holding stock stock today? What is the projected target price level for 2021? How much will it cost in 2021? Biohaven Pharmaceutical Holding stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2021.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $101.45 target price for Biohaven Pharmaceutical Holding stock stock.

Today 200 Day Moving Average is the support level (80.7857 $).

50 Day Moving Average is the support level (77.8086 $).




BHVN Forecast for 2021

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jul 112.56 105.14 117.64 10.63 %
Aug 118.63 108.45 128.68 15.72 %
Sep 115.24 106.87 124.49 14.15 %
Oct 111.69 108.13 115.38 6.28 %
Nov 104.56 102.15 106.86 4.41 %
Dec 105.94 99.88 113.75 12.19 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Biohaven Pharmaceutical Holding stock.


Biohaven Pharmaceutical Holding overview

Biohaven Pharmaceutical Holding Address

215 Church Street, New Haven, CT, United States, 06510

Market Capitalization

6 577 344 000 $

EBITDA

-356 321 504

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-9.14

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

37.074

Trailing PE

0

Forward PE

0

EV To Revenue

55.5974

EV To EBITDA

0

52 Week High

103.83

52 Week Low

57.66

50 Day Moving Average

77.8086

200 Day Moving Average

80.7857

Shares Outstanding

65073900

Shares Float

55023903

Shares Short Prior Month

5358166

Short Ratio

11.64

Percent Insiders

12.371

Percent Institutions

95.171

Biohaven Pharmaceutical Holding stock forecast for this year


Biohaven Pharmaceutical Holding stock forecast for Jul 2021.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 112.56. Positive monthly dynamics of the instrument is expected with 10.631% volatility is expected.

Pessimistic forecast: 105.14

Optimistic: 117.64


Biohaven Pharmaceutical Holding stock forecast for Aug 2021.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 118.63. Positive monthly dynamics of the instrument is expected with 15.719% volatility is expected.

Pessimistic forecast: 108.45

Optimistic: 128.68


Biohaven Pharmaceutical Holding stock forecast for Sep 2021.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 115.24. Negative monthly dynamics of the instrument is expected with 14.154% volatility is expected.

Pessimistic forecast: 106.87

Optimistic: 124.49


Biohaven Pharmaceutical Holding stock forecast for Oct 2021.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 111.69. Negative monthly dynamics of the instrument is expected with 6.282% volatility is expected.

Pessimistic forecast: 108.13

Optimistic: 115.38


Biohaven Pharmaceutical Holding stock forecast for Nov 2021.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 104.56. Negative monthly dynamics of the instrument is expected with 4.413% volatility is expected.

Pessimistic forecast: 102.15

Optimistic: 106.86


Biohaven Pharmaceutical Holding stock forecast for Dec 2021.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 105.94. Positive monthly dynamics of the instrument is expected with 12.192% volatility is expected.

Pessimistic forecast: 99.88

Optimistic: 113.75



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 110.48 (14.06.2021) 0.52 %
AbbVie Inc.
ABBV 115.4 (14.06.2021) -0.02 %
Aeterna Zentaris Inc.
AEZS 1.02 (14.06.2021) -2.86 %
Allakos Inc.
ALLK 90.87 (14.06.2021) -3.24 %
Allogene Therapeutics, Inc.
ALLO 25.37 (14.06.2021) -2.80 %
Amgen Inc.
AMGN 241.19 (14.06.2021) -0.65 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (14.06.2021) 1.81 %
Aurora Cannabis Inc.
ACB 9.67 (14.06.2021) -1.53 %
Becton Dickinson and Company
BDX 242.72 (14.06.2021) 0.03 %
Biogen Inc.
BIIB 406.14 (14.06.2021) 2.40 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 100.4 (14.06.2021) -4.40 %
BioNTech SE
BNTX 220.58 (14.06.2021) -7.53 %
bluebird bio, Inc.
BLUE 33.53 (14.06.2021) -1.67 %
Boston Scientific Corp.
BSX 42.54 (14.06.2021) -0.86 %
Bristol-Myers Squibb Company
BMY 67.29 (14.06.2021) -0.07 %
Canopy Growth Corp.
CGC 25.14 (14.06.2021) -2.82 %
Castle Biosciences, Inc.
CSTL 71.86 (14.06.2021) -0.04 %
Eli Lilly and Company
LLY 226.1 (14.06.2021) 0.90 %
Emergent BioSolutions Inc.
EBS 61.79 (14.06.2021) -2.71 %
Exelixis, Inc.
EXEL 22.76 (14.06.2021) -0.96 %
G1 Therapeutics, Inc.
GTHX 22.75 (14.06.2021) 5.23 %
Gilead Sciences, Inc.
GILD 68.15 (14.06.2021) -0.90 %
GlaxoSmithKline plc
GSK 40.49 (14.06.2021) 0.85 %
GoodRx Holdings, Inc.
GDRX 38.33 (14.06.2021) 4.21 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 82.64 (14.06.2021) 0.07 %
Inovio Pharmaceuticals, Inc.
INO 8.91 (14.06.2021) -2.09 %
Johnson & Johnson
JNJ 165.37 (14.06.2021) 0.25 %
Medtronic plc.
MDT 124.15 (14.06.2021) 0.30 %
Merck & Co., Inc.
MRK 75.45 (14.06.2021) -1.08 %
Moderna, Inc.
MRNA 207.41 (14.06.2021) -5.23 %
Novartis AG
NVS 93.59 (14.06.2021) 0.97 %
Novavax, Inc.
NVAX 207.71 (14.06.2021) -0.94 %
ObsEva SA
OBSV 3.17 (14.06.2021) -0.63 %
OrganiGram Holdings Inc.
OGI 3.14 (14.06.2021) -1.26 %
Pfizer Inc.
PFE 39.63 (14.06.2021) -1.30 %
Regeneron Pharmaceuticals, Inc.
REGN 528.75 (14.06.2021) 0.61 %
Sanofi
SNY 54.25 (14.06.2021) 0.84 %
Schrodinger, Inc.
SDGR 76.34 (14.06.2021) -1.51 %
Senseonics Holdings, Inc.
SENS 3.96 (14.06.2021) -1.25 %
Sorrento Therapeutics, Inc.
SRNE 9.46 (14.06.2021) 6.65 %
Stryker Corp.
SYK 255.69 (14.06.2021) -0.04 %
Sundial Growers Inc.
SNDL 1.06 (14.06.2021) 0.95 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 11.05 (14.06.2021) -0.54 %
Thermo Fisher Scientific Inc.
TMO 470.07 (14.06.2021) 1.06 %
Tilray, Inc.
TLRY 19.16 (14.06.2021) -3.67 %
UnitedHealth Group, Inc.
UNH 399.16 (14.06.2021) 0.32 %
Veeva Systems Inc.
VEEV 303.9 (14.06.2021) 1.57 %
Zomedica Corp.
ZOM 0.9458 (14.06.2021) -0.08 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.66 (14.06.2021) 0.35 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.